drugset / Trial / NCT01797107
Study to Determine the Effect of Azasite on Corneal Surface Irregularity
Phase 2
Withdrawn
Philadelphia Eye Associates
Merck Sharp & Dohme LLC · collabThomas Jefferson University · collab
RandomizedSingle-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the effect of Azasite on patients with corneal surface irregularity (meibomian gland dysfunction).
Timeline
- Start
- 2013-03
- Primary completion
- 2014-07
- Completion
- 2014-07
Outcome
Outcome not reported
Stopped (Enrollment): “Lack of enrollment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azithromycin | Small molecule | 1 % | — |